These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9420793)

  • 1. Effect of beta-blockade on regional left ventricular function in patients with dilated cardiomyopathy.
    Morozumi T; Ishida Y; Kusuoka H; Sato H; Hori M; Kamada T; Nishimura T
    J Nucl Cardiol; 1995; 2(3):231-7. PubMed ID: 9420793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS
    Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Masson S; Masseroli M; Fiordaliso F; Calvillo L; D'Aquila S; Bernasconi R; Garrido G; Torri M; Razzetti R; Bongrani S; Latini R
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP; Miller WL
    Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function.
    Spinale FG; Holzgrefe HH; Mukherjee R; Hird RB; Walker JD; Arnim-Barker A; Powell JR; Koster WH
    Circulation; 1995 Aug; 92(3):562-78. PubMed ID: 7634471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of beta-adrenergic blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy.
    Kim MH; Devlin WH; Das SK; Petrusha J; Montgomery D; Starling MR
    Circulation; 1999 Aug; 100(7):729-35. PubMed ID: 10449695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
    J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy.
    Green P; Anshelevich M; Talreja A; Burcham JL; Ravi SM; Shirani J; Le Jemtel TH
    Am J Cardiol; 2005 May; 95(9):1114-6. PubMed ID: 15842987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Therapy Leads to Favorable Remodeling in Left Ventricular Non-compaction Cardiomyopathy: Dilated Phenotype.
    Parent JJ; Towbin JA; Jefferies JL
    Pediatr Cardiol; 2016 Apr; 37(4):674-7. PubMed ID: 26724283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study.
    Circulation; 2000 Feb; 101(4):378-84. PubMed ID: 10653828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin withdrawal in patients with dilated cardiomyopathy following normalization of ejection fraction with beta blockers.
    Shammas NW; Harris ML; McKinney D; Hauber WJ
    Clin Cardiol; 2001 Dec; 24(12):786-7. PubMed ID: 11768743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathy.
    Regitz-Zagrosek V; Leuchs B; Krülls-Münch J; Fleck E
    Am Heart J; 1995 Apr; 129(4):754-61. PubMed ID: 7900628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade.
    Hall SA; Cigarroa CG; Marcoux L; Risser RC; Grayburn PA; Eichhorn EJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1154-61. PubMed ID: 7897129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.